GHK-Cu is a naturally occurring glycyl-L-histidyl-L-lysine tripeptide complexed with copper(II), widely researched in preclinical models for collagen synthesis, dermal remodeling, and wound closure. PX1 Research supplies high-purity research-grade GHK-Cu backed by US-based peptide synthesis, third-party lot-specific HPLC/MS and endotoxin verification, and same-day shipping M–F from California and Arizona facilities.
GHK-Cu is a naturally occurring glycyl-L-histidyl-L-lysine tripeptide complexed with copper(II), widely researched in preclinical models for collagen synthesis, dermal remodeling, and wound closure. PX1 Research supplies high-purity research-grade GHK-Cu backed by US-based peptide synthesis, third-party lot-specific HPLC/MS and endotoxin verification, and same-day shipping M–F from California and Arizona facilities.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring human tripeptide with an exceptionally high affinity for divalent copper ions (Cu2+). First isolated from human plasma in 1973, it functions in biological systems as a signal peptide and micronutrient carrier.
Preclinical research demonstrates that GHK-Cu modulates extracellular matrix remodeling by upregulating collagen and elastin synthesis while suppressing excess fibrotic tissue formation. In vitro and animal models indicate that the compound regulates over 4,000 human genes, particularly those associated with cellular repair, antioxidant activity, and wound closure.
To maintain rigorous scientific reproducible results, researchers require reference materials verified for purity, sequence identity, and endotoxin levels. PX1 Research provides fully documented, US-synthesized GHK-Cu tailored for analytical and in vitro investigative protocols.
Chemically, GHK-Cu consists of the tripeptide Glycyl-L-Histidyl-L-Lysine non-covalently chelated to a single copper(II) ion. The peptide backbone features a specific spatial conformation that allows the nitrogen atoms of the histidine imidazole ring, the terminal glycine amine, and the peptide bonds to coordinate tightly with Cu2+ with an association constant of approximately 10^13 M^-1.
In biological systems, copper serves as a necessary cofactor for enzymes such as superoxide dismutase (SOD) and lysyl oxidase (LOX). By chelating copper, the GHK peptide acts as a controlled delivery mechanism that regulates intracellular and extracellular copper availability without generating toxic free radical copper ions.
Detailed chemical structural analyses and sequence characterization are available in our GHK-Cu research overview, which details the physical properties and historical discovery of the molecule in preclinical literature.
In preclinical cell culture and animal tissue models, GHK-Cu exhibits a multifaceted mechanism of action centered on gene transcription and extracellular matrix (ECM) reorganization. Genomic profiling studies indicate that GHK-Cu shifts gene expression toward tissue restoration by modulating both upregulatory and downregulatory pathways.
The primary molecular mechanisms observed in vitro include:
• ECM Synthesis Upregulation: Stimulates mRNA expression and protein production of Type I, Type III, and Type IV collagens, as well as elastin, decorin, and glycosaminoglycans (GAGs).
• Matrix Metalloproteinase Regulation: Balances tissue turnover by modulating Matrix Metalloproteinases (MMP-1, MMP-2) and their corresponding inhibitors (TIMP-1, TIMP-2), facilitating controlled structural matrix remodeling.
• Anti-Inflammatory Signaling: Downregulates pro-inflammatory cytokines such as TNF-alpha and IL-6 while suppressing NF-kB pathway activation in macrophage cell lines.
• Antioxidant Defense Enrichment: Increases gene expression of superoxide dismutase (SOD-1), glutathione, and catalase, reducing oxidative stress markers in cellular injury assays.
In rodent and porcine models of dermal injury, GHK-Cu has been heavily researched for its capacity to accelerate wound closure while preventing pathological fibrosis. During the early inflammatory phase of repair, the tripeptide acts as a chemoattractant for macrophages, mast cells, and capillary endothelial cells, expediting the clearance of necrotic debris.
As repair progresses into the proliferative phase, GHK-Cu enhances fibroblast proliferation and stimulates localized angiogenesis by upregulating vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). This increased vascularization provides essential nutrients to newly forming granulation tissue.
Crucially, GHK-Cu demonstrates a unique capacity to reduce fibrotic scarring. By normalizing Transforming Growth Factor-beta (TGF-beta1) signaling, it encourages organized, parallel collagen fibril alignment rather than the disorganized, hyper-crosslinked collagen bundles characteristic of hypertrophic scars. Laboratories investigating tissue engineering and regenerative repair can order 50 mg GHK-Cu vials directly from PX1 Research for high-throughput cellular screening.
Researchers evaluating matrix-modulating compounds often compare GHK-Cu to other structural tripeptides, non-chelated peptides, or systemic tissue-repair molecules. Understanding these differences allows principal investigators to select the precise tool for their experimental design.
• GHK-Cu vs. Unbound GHK: Unbound GHK lacks the chelated copper ion. While GHK alone retains basic gene signaling properties, it lacks the enzymatic activation capabilities provided by Cu2+ delivery to copper-dependent enzymes like lysyl oxidase.
• GHK-Cu vs. AHK-Cu: AHK-Cu (Alanine-Histidine-Lysine copper complex) shares structural similarities but displays higher selectivity toward follicular keratinocyte culture models compared to the broad ECM activity of GHK-Cu.
• GHK-Cu vs. BPC-157: While GHK-Cu focuses heavily on localized dermal collagen synthesis and extracellular matrix regulation, BPC-157 is a pentadecapeptide primarily investigated for systemic gastrointestinal integrity and tendon-to-bone junction repair.
• GHK-Cu vs. TB-500: TB-500 works via actin-sequestering mechanisms to promote cell migration, whereas GHK-Cu directly regulates structural protein transcription and enzymatic matrix turnover.
To review additional matrix-active and tissue-repair compounds, researchers can browse the full catalog of research peptides.
Because GHK-Cu interacts directly with cell surface receptors and enzymatic pathways, chemical impurities or unchelated heavy metals can invalidate experimental results. Laboratories must verify specific physical and analytical parameters before introducing reference material into cell culture or tissue assays.
Key quality benchmarks for analytical-grade GHK-Cu include:
1. HPLC Purity: Must show a sharp, single main peak exceeding 98.0% purity by High-Performance Liquid Chromatography.
2. Mass Spectrometry Verification: Electrospray ionization mass spectrometry (ESI-MS) must confirm exact molecular weight, matching both the free peptide mass and the expected copper-complex ion distribution.
3. Characteristic Physical Appearance: Authentic GHK-Cu exists as a fine, intense royal blue lyophilized powder. A pale blue or off-white color indicates incomplete copper chelation or degraded raw materials.
4. Endotoxin Content: Must test under 0.1 EU/mg via Kinetic Chromogenic LAL assay to prevent non-specific macrophage activation in cell culture.
5. Solubility Parameters: Rapidly and completely soluble in standard sterile aqueous buffers, including phosphate-buffered saline (PBS) and sterile water for injection, without requiring organic co-solvents.
Selecting a reliable research peptide vendor requires transparent documentation and consistent manufacturing standards. Below is an objective comparison of PX1 Research standards against common market practices.
• Chemical Purity Verification: PX1 Research conducts independent, third-party HPLC testing on every individual lot to guarantee >= 98% purity. Industry standard suppliers frequently rely on non-verified factory self-reports.
• Endotoxin & Bioburden Testing: PX1 Research verifies <0.1 EU/mg endotoxin levels per lot via LAL assays. Standard vendors rarely test for bacterial endotoxins in research-grade catalog items.
• Synthesis & Quality Control: PX1 Research utilizes US-based solid-phase peptide synthesis (SPPS) with strict cold-chain handling. Discount vendors often source unverified, mass-produced imported batches with variable copper stoichiometry.
• Lot Traceability: PX1 Research prints unique lot numbers directly on vial labels, linking directly to downloadable, lot-specific COAs. Generic vendors often reuse static, outdated COA PDFs across multiple production runs.
• Shipping Speed & Logistics: PX1 Research dispatches orders same-day (M–F before 3 PM EST) from domestic hubs in California and Arizona. Overseas or drop-shipping suppliers involve prolonged transit times and temperature fluctuations.
• Technical Support: PX1 Research provides dedicated support managed by scientific specialists familiar with peptide stability and handling protocols.
When procuring reference compounds for scientific experiments, identifying vendor red flags saves research time and institutional funding. Be cautious of suppliers displaying the following practices:
• Shared or Missing COAs: Avoid suppliers that fail to provide a direct, downloadable Certificate of Analysis matching your exact lot number. Reusing old COAs indicates a lack of testing for new synthesis batches.
• Incorrect Powder Appearance: GHK-Cu must exhibit a deep blue hue. Vendors supplying white, grey, or pale sky-blue powder are shipping unchelated GHK tripeptide or degraded material.
• Absence of Endotoxin Data: Uncontrolled bacterial endotoxins induce robust inflammatory cytokine releases in tissue assays, confounding cellular response data in inflammatory and wound healing models.
• Medical or Clinical Claims: Suppliers asserting human therapeutic efficacy, offering dosing calculators, or marketing peptides for personal cosmetic use violate regulatory guidelines and typically lack analytical rigor.
For additional guidance on evaluating peptide stability and analytical testing parameters, visit the PX1 Research knowledge base.
Proper handling and reconstitution protocols preserve the structural integrity of the GHK-Cu complex. Researchers should adhere to sterile laboratory procedures when working with lyophilized peptide vials.
1. Reconstitution: Allow the vial to equilibrate to room temperature before reconstitution. Add sterile bacteriostatic water or sterile PBS by directing the stream along the glass vial wall. Gently swirl the vial until the deep blue powder completely dissolves; avoid vigorous vortexing to prevent protein foaming.
2. Concentration & Solution Color: Upon reconstitution, the solution will display a clear, transparent dark blue color. Cloudiness or precipitation indicates buffer incompatibility or contamination.
3. Aliquoting & Storage: To prevent repeated freeze-thaw cycles that break peptide bonds, aliquot the reconstituted solution into sterile microcentrifuge tubes. Store long-term stock solutions at -20°C or -80°C. Short-term working solutions may be stored at 4°C for up to 14 days protected from direct light.
4. High-Throughput Orders: Industrial and academic facilities executing large-scale screening protocols can utilize the PX1 Research bulk peptide program for volume pricing and custom batch reservations.
When purchasing reference material from PX1 Research, laboratory buyers receive fully characterized, high-purity GHK-Cu engineered for rigorous experimental reproducibility. Each order ships in secure, vacuum-sealed packaging with protective amber or clear borosilicate glass vials to guard against light degradation and atmospheric moisture.
PX1 Research stocks GHK-Cu in standard 10 mg and 50 mg laboratory vial sizes. Orders placed prior to 3:00 PM EST Monday through Friday dispatch the same day from our primary shipping hubs in California and Arizona. Expedited, fully tracked domestic transit options ensure your research schedule remains uninterrupted.
Every batch includes instant online access to its corresponding lot-specific Certificate of Analysis detailing HPLC purity, mass spectrometry, and endotoxin assay results. Ready to supply your laboratory? Navigate directly to GHK-Cu lyophilized powder to select your required quantity and complete your order.
Is GHK-Cu legal to buy in the US?
Yes, GHK-Cu is legal to purchase in the United States as a laboratory research chemical. It is strictly designated for in vitro, cell culture, and preclinical scientific study. It is not approved or intended for human consumption, clinical treatment, or cosmetic application.
How fast does PX1 Research ship GHK-Cu orders?
Orders placed before 3:00 PM EST Monday through Friday ship the same day from our domestic distribution centers in California and Arizona. Standard domestic transit typically takes 2 to 4 business days, complete with real-time tracking information.
Do you provide a COA for my lot of GHK-Cu?
Yes, every batch of GHK-Cu supplied by PX1 Research includes a downloadable, lot-specific Certificate of Analysis. The COA details mass spectrometry identity confirmation, HPLC analytical purity (>= 98%), and LAL endotoxin testing results.
What purity level is PX1 Research GHK-Cu?
PX1 Research guarantees a minimum purity of 98.0% by High-Performance Liquid Chromatography (HPLC) for all GHK-Cu lots. Our peptide synthesis processes ensure minimal truncated peptide impurities or unchelated free copper.
What is the difference between GHK and GHK-Cu?
GHK is the raw tripeptide sequence (Glycyl-L-Histidyl-L-Lysine). GHK-Cu is the identical tripeptide chelated to a divalent copper ion (Cu2+). Chelation with copper is required to activate copper-dependent enzymatic processes in tissue remodeling research.
Why is GHK-Cu lyophilized powder blue?
The distinct royal blue color is caused by d-d electron transitions within the chelated divalent copper ion (Cu2+) bound to the histidine and amine nitrogen atoms of the tripeptide chain. White or pale powder indicates a lack of copper coordination.
What solvent should be used to reconstitute GHK-Cu for in vitro assays?
GHK-Cu is highly water-soluble. It reconstitutes easily in sterile bacteriostatic water, sterile water for injection, or standard phosphate-buffered saline (PBS, pH 7.4). Organic solvents like DMSO are not required.
How should research labs store GHK-Cu long-term?
Lyophilized GHK-Cu powder should be stored desiccated at -20°C or -80°C protected from light, where it remains stable for up to 24 months. Once reconstituted in liquid buffer, store aliquots at -20°C to avoid freeze-thaw cycles.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.